Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hysterectomy | 2 | 2024 | 71 | 1.570 |
Why?
|
| Laparoscopy | 2 | 2021 | 388 | 1.070 |
Why?
|
| Leiomyoma | 1 | 2024 | 17 | 0.910 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 31 | 0.900 |
Why?
|
| Abdominal Neoplasms | 1 | 2021 | 17 | 0.730 |
Why?
|
| Abdominal Muscles | 1 | 2020 | 6 | 0.710 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 332 | 0.690 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2020 | 42 | 0.690 |
Why?
|
| Nerve Block | 1 | 2020 | 40 | 0.670 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 145 | 0.650 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 129 | 0.650 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 97 | 0.630 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 323 | 0.590 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2015 | 220 | 0.220 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 348 | 0.200 |
Why?
|
| Ischemia | 2 | 2015 | 192 | 0.200 |
Why?
|
| Adult | 4 | 2024 | 15771 | 0.190 |
Why?
|
| Neoplasm Seeding | 1 | 2021 | 3 | 0.180 |
Why?
|
| Abdominal Wall | 1 | 2021 | 21 | 0.180 |
Why?
|
| Pain Measurement | 1 | 2020 | 330 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2473 | 0.140 |
Why?
|
| Female | 4 | 2024 | 30895 | 0.140 |
Why?
|
| Middle Aged | 3 | 2024 | 16259 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2327 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 102 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2024 | 6007 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2013 | 36 | 0.110 |
Why?
|
| Operative Time | 1 | 2013 | 63 | 0.110 |
Why?
|
| Breast Diseases | 1 | 2013 | 39 | 0.110 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 98 | 0.100 |
Why?
|
| Humans | 6 | 2024 | 59471 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5098 | 0.100 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 207 | 0.100 |
Why?
|
| Retina | 1 | 2012 | 119 | 0.090 |
Why?
|
| Hypoglycemia | 1 | 2012 | 68 | 0.090 |
Why?
|
| Mammography | 1 | 2013 | 272 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2020 | 5174 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2012 | 176 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 1097 | 0.080 |
Why?
|
| Aged | 2 | 2020 | 13342 | 0.070 |
Why?
|
| Hindlimb | 2 | 2015 | 44 | 0.060 |
Why?
|
| Muscle, Skeletal | 2 | 2015 | 673 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 1988 | 0.040 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 25 | 0.030 |
Why?
|
| Femoral Artery | 1 | 2015 | 93 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2015 | 2887 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2015 | 176 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 309 | 0.030 |
Why?
|
| Mastectomy, Segmental | 1 | 2013 | 45 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 95 | 0.030 |
Why?
|
| Necrosis | 1 | 2012 | 138 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 138 | 0.020 |
Why?
|
| Chickens | 1 | 2012 | 91 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 19649 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 594 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 10274 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 847 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1538 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2099 | 0.020 |
Why?
|
| Male | 2 | 2015 | 27561 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4321 | 0.010 |
Why?
|